|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 701 PENNSYLVANIA AVENUE, N.W., SUITE 800 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 17831-12
|
||||||||
|
6. House ID# 310010000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: DAVID H. NEXON, SENIOR EXECUTIVE VICE PRESIDENT |
Date | 04/21/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 2184 - Enhanced Health Care Value for All Act of 2007 - A bill to amend the Medicare Prescription Drug, Improvement & Modernizaton Act of 2003 to expand comparative effectiveness research and to increase funding for such research to improve the value of health care. [Julie Cohen, David Nexon, Seth Radus, Amy Cunniffe] /// Other issues: Preemption, Budget Resolution (HCR 312/SCR 70), and Import Safety [David Nexon, Seth Radus, Amy Cunniffe, Julie Cohen]
HR 1561/ S 484 - Enhancing Drug Safety and Innovation Act of 2007 (Introduced in House)/ (Introduced in Senate) - A bill to amend the Public Health Service Act and the Federal Food, Drug and Cosmetic Act to improve drug safety and oversight. [Seth Radus, David Nexon, Amy Cunniffe]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), White House Office, Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Cohen |
|
|
|
David |
Nexon |
|
|
|
Seth |
Radus |
|
|
|
Amy |
Cunniffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S 631 - Remote Monitoring Access Act of 2007. A bill to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program. [Julie Cohen, Seth Radus, David Nexon]
HR 1321/S 2404 - Medicaid Advanced Laboratory Diagnostics Act of 2007. A bill to improve payments under the Medicare clinical laboratory fee schedule. [Julie Cohen, Seth Radus]
S 736 - Laboratory Test Improvement Act [David Nexon, Amy Cunniffe]
HR 1293 - Access to Medicare Imaging Act - A bill to provide for a 2-year moratorium on certain Medicare physician payment reductions for advanced diagnostic imaging services [Seth Radus, David Nexon, Amy Cunniffe]
HR 1926 // S 1164 - Colon Cancer Screen for Life Act [David Nexon, Amy Cunniffe]
HR 3162 - Children's Health and Medicare Protection Act of 2007 - A bill to extend and improve the children's health insurance program, to improve beneficiary protections under the Medicare, Medicaid, and the CHIP program. [Amy Cunniffe, David Nexon]
S 2029 // HR 5605 - Physician Payments Sunshine Act of 2007 - a bill to provide transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP (Also previous DeFazio bill) [Seth Radus, David Nexon, Julie Cohen, Amy Cunniffe]
S 2221 - Transparency in Medical Device Pricing Act of 2007 - A bill to provide for the reporting of sales price data for implantable medical devices [Seth Radus, Julie Cohen, Amy Cunniffe, David Nexon]
HR 3023 - Drug and Medical Device Company Gift Disclosure Act - A bill to require the manufacturers, packers, and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities [Seth Radus, Julie Cohen, Amy Cunniffe, David Nexon]
17. House(s) of Congress and Federal agencies Check if None
Administration on Aging, U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Cohen |
|
|
|
David |
Nexon |
|
|
|
Seth |
Radus |
|
|
|
Amy |
Cunniffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S 976 - Genomics and Personalized Medicine Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agency for Health Care Policy & Research, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
David |
Nexon |
|
|
|
Julie |
Cohen |
|
|
|
Seth |
Radus |
|
|
|
Amy |
Cunniffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
HR 3567 - Small Business Ivestment Expansion Act of 2007 - A bill to expand opportunities for investments in small businesses. [Julie Cohen, Seth Radus, David Nexon, Amy Cunniffe]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Commerce - Dept of (DOC), Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Cohen |
|
|
|
Seth |
Radus |
|
|
|
David |
Nexon |
|
|
|
Amy |
Cunniffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
HR 2419 - Farm Bill Extension Act of 2007: A bill to provide for the continuation of agricultural programs through fiscal year 2012. Main concern is on the animal testing mentioned in bill. [Seth Radus, Amy Cunniffe, David Nexon]
HR 1280 - Pet Safety and Protection Act of 2007 (Introduced in House) - A bill to amend the Animal Welfare Act to ensure that all dogs and cats used by research facilities are obtained legally [Seth Radus, Amy Cunniffe, David Nexon]
S 736 - Laboratory Test Improvement Act (Introduced in Senate) - A bill to provide for the regulation and oversight of laboratory tests [Seth Radus, David Nexon, Amy Cunniffe]
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Cunniffe |
|
|
|
Seth |
Radus |
|
|
|
David |
Nexon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
HR 1908 / S 1145 - Patent Reform Act of 2007 - A bill to provide patent reform (Seth Radus, David Nexon, Amy Cunniffe)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Patent & Trademark Office (PTO), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Seth |
Radus |
|
|
|
David |
Nexon |
|
|
|
Amy |
Cunniffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: www.advamed.org (list of member companies that are affiliated with Advanced Medical Technology Assoc.)
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |